Clinical challenges in co-occurring borderline personality and substance use disorders

Psychiatric Times

Volumn 23, Issue 13, 2006, Pages 16-18

  Gregory, Robert J ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33845381948     PISSN: 08932905     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Dulit RA, Fyer MR, Haas GL, et al. Substance use in borderline personality disorder. Am J Psychiatry. 1990;147:1002-1007.
2. Zanarini MC, Frankenburg FR, Hennen J, et al. Axis I comorbidity in patients with borderline personality disorder: 6-year follow-up and prediction of time to remission. Am J Psychiatry. 2004;161:2108-2114.
3. Kleinman PH, Miller AB, Millman RB, et al. Psychopathology among cocaine abusers entering treatment. J Nerv Ment Dis. 1990;178:442-447.
4. Marlowe DB, Kirby KC, Festinger DS, et al. Impact of comorbid personality disorders and personality disorder symptoms on outcomes of behavioral treatment for cocaine dependence. J Nerv Ment Dis. 1997;185:483-490.
5. Kranzler HR, Satel S, Apter A. Personality disorders and associated features in cocaine-dependent inpatients. Compr Psychiatry. 1994;35:335-340.
6. Cacciola JS, Rutherford MJ, Alterman AI, et al. Personality disorders and treatment outcome in methadone maintenance patients. J Nerv Ment Dis. 1996;184:234-239.
7. Cacciola JS, Alterman AI, Rutherford MJ, et al. The relationship of psychiatric comorbidity to treatment outcomes in methadone maintained patients. Drug Alcohol Depend. 2001;61:271-280.
8. Brooner RK, King VL, Kidorf M, et al. Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Arch Gen Psychiatry. 1997;54:71-80.
9. Darke S, Ross J, Williamson A, Teesson M. The impact of borderline personality disorder on 12-month outcomes for the treatment of heroin dependence. Addiction. 2005;100:1121-1130.
10. Nurnberg HG, Rifkin A, Doddi S. A systematic assessment of the comorbidity of DSM-III-R personality disorders in alcoholic outpatients. Compr Psychiatry. 1993;34:447-454.
11. Morgenstern J, Langenbucher J, Labouvie E, Miller KJ. The comorbidity of alcoholism and personality disorders in a clinical population: prevalence rates and relation to alcohol typology variables. J Abnorm Psychol. 1997;106:74-84.
12. Martinez-Raga J, Marshall EJ, Keaney F, et al. Unplanned versus planned discharges from in-patient alcohol detoxification: retrospective analysis of 470 first-episode admissions. Alcohol Alcohol. 2002;37:277-281.
13. Miller FT, Abrams T, Dulit R, Fyer M. Substance abuse in borderline personality disorder. Am J Drug Alcohol Abuse. 1993;19:491-497.
14. van den Bosch LM, Verheul R, van den Brink W. Substance abuse in borderline personality disorder: clinical and etiological correlates. J Personal Disord. 2001;15:416-424.
15. Pirkola SP, Isometsa ET, Heikkinen ME, et al. Female psychoactive substance-dependent suicide victims differ from male - results from a nationwide psychological autopsy study. Compr Psychiatry. 1999;40:101-107.
16. Ryle A, Golynkina K. Effectiveness of time-limited cognitive analytic therapy of borderline personality disorder: factors associated with outcome. Br J Med Psychol. 2000;73:197-210.
17. van den Bosch LM, Verheul R, Schippers GM, van den Brink W. Dialectical behavior therapy of borderline patients with and without substance use problems: implementation and long-term effects. Addict Behav. 2002;27:911-923.
18. Trull TJ, Sher KJ, Minks-Brown C, et al. Borderline personality disorder and substance use disorders: a review and integration. Clin Psychol Rev. 2000;20:235-253.
19. Goodwin DW, Gabrielli WF Jr, Penick EC, et al. Breastfeeding and alcoholism: the Trotter hypothesis. Am J Psychiatry. 1999;156:650-652.
20. Sorensen HJ, Mortensen EL, Reinisch JM, Mednick SA. Early weaning and hospitalization with alcohol-related diagnoses in adult life. Am J Psychiatry. 2006;163:704-709.
21. Barr CS, Newman TK, Lindell S, et al. Interaction between serotonin transporter gene variation and rearing condition in alcohol preference and consumption in female primates. Arch Gen Psychiatry. 2004;61:1146-1152.
22. Moles A, Kieffer BL, D'Amato FR. Deficit in attachment behavior in mice lacking the mu-opioid receptor gene. Science. 2004;304:1983-1986.
23. Binks CA, Fenton M, McCarthy L, et al. Pharmacological interventions for people with borderline personality disorder. Cochrane Database Syst Rev. 2006;(1):CD005653.
24. American Psychiatric Association. Practice guideline for the treatment of patients with borderline personality disorder. Am J Psychiatry. 2001;158(suppl 10):1-52.
25. Cowdry RW, Gardner DL. Pharmacotherapy of borderline personality disorder. Alprazolam, carbamazepine, trifluoperazine, and tranylcypromine. Arch Gen Psychiatry. 1988;45:111-119.
26. Linehan MM, Armstrong HE, Suarez A, et al. Cognitive-behavioral treatment of chronically parasuicidal borderline patients. Arch Gen Psychiatry. 1991;48:1060-1064.
27. Linehan MM, Schmidt H 3rd, Dimeff LA, et al. Dialectical behavior therapy for patients with borderline personality disorder and drug-dependence. Am J Addict. 1999;8:279-292.
28. Linehan MM, Dimeff LA, Reynolds SK, et al. Dialectical behavior therapy versus comprehensive validation therapy plus 12-step for the treatment of opioid dependent women meeting criteria for borderline personality disorder. Drug Alcohol Depend. 2002;67:13-26.
29. Giesen-Bloo J, van Dyck R, Spinhoven P, et al. Outpatient psychotherapy for borderline personality disorder: randomized trial of schema-focused therapy vs transference-focused psychotherapy. Arch Gen Psychiatry. 2006;63:649-658.
30. Ball SA. Manualized treatment for substance abusers with personality disorders: dual focus schema therapy. Addict Behav. 1998;23:883-891.
31. Bateman A, Fonagy P. Effectiveness of partial hospitalization in the treatment of borderline personality disorder: a randomized controlled trial. Am J Psychiatry. 1999;156:1563-1569.
32. Bateman A, Fonagy P. Treatment of borderline personality disorder with psychoanalytically oriented partial hospitalization: an 18-month follow-up. Am J Psychiatry. 2001;158:36-42.
33. Clarkin JF, Foelsch PA, Levy KN, et al. The development of a psychodynamic treatment for patients with borderline personality disorder: a preliminary study of behavioral change. J Personal Disord. 2001;15:487-495.
34. Gregory RJ. Thematic stages of recovery in the treatment of borderline personality disorder. Am J Psychother. 2004;58:335-348.
35. Gregory RJ. The deconstructive experience. Am J Psychother. 2005;59:295-305.
36. Kamo MP, Longabaugh R. Less directiveness by therapists improves drinking outcomes of reactant clients in alcoholism treatment. J Consult Clin Psychol. 2005;73:262-267.
37. Gregory RJ. Psychodynamic therapy for co-occuring borderline personality disorder and alcohol use disorder: a newly designed ongoing study. Presented at: 159th Annual Meeting of the American Psychiatric Association; May 20-25, 2006; Toronto.
38. American Psychiatric Association. Practice guideline for the treatment of patients with borderline personality disorder. Am J Psychiatry. 2001;158(suppl 10):1-52.
39. Binks CA, Fenton M, McCarthy L, et al. Pharmacological interventions for people with borderline personality disorder. Cochrane Database Syst Rev. 2006;(1):CD005653.